(BUD) Anheuser Busch Inbev - Ratings and Ratios
Exchange: NYSE • Country: Belgium • Currency: USD • Type: Common Stock • ISIN: US03524A1088
BUD: Beer, Beverages
Anheuser-Busch InBev stands as the worlds largest brewer, with a footprint that spans the globe. Their operations encompass the production, distribution, and marketing of beverages, primarily focusing on beer. This multinational company has a history dating back to 1366, underscoring its enduring presence in the industry. Headquartered in Leuven, Belgium, AB InBevs strategic position allows it to leverage a vast distribution network and significant market share.
The company boasts an impressive portfolio of over 500 beer brands, each catering to diverse consumer preferences. Flagship brands like Budweiser, Corona, and Stella Artois are household names, while regional gems such as Becks and Hoegaarden maintain strong local followings. This strategic diversification not only broadens market reach but also mitigates risks associated with relying on a single brand. Additionally, their portfolio includes Michelob Ultra and Bud Light, which have shown robust growth in the health-conscious and low-calorie segments.
With operations in North America, South America, Europe, the Middle East, Africa, and the Asia Pacific, AB InBevs global reach is unparalleled. This extensive network is supported by a distribution system that ensures their products are accessible across various markets. Their market leadership is further bolstered by a focus on efficiency and innovation, allowing them to maintain profitability even in competitive environments.
Financially, AB InBev presents a compelling case for investors. With a market capitalization of approximately $96506.32M USD, the company is a significant player in the consumer staples sector. The price-to-earnings ratio of 15.57 and a forward P/E of 13.61 indicate a valuation that aligns with its growth prospects. The price-to-book ratio of 1.24 and price-to-sales ratio of 1.62 highlight the companys asset efficiency and profitability margins, making it an attractive option for those seeking stability and growth in the beverage industry.
Additional Sources for BUD Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BUD Stock Overview
Market Cap in USD | 119,925m |
Sector | Consumer Defensive |
Industry | Beverages - Brewers |
GiC Sub-Industry | Brewers |
IPO / Inception | 2009-07-01 |
BUD Stock Ratings
Growth 5y | 19.4% |
Fundamental | 16.4% |
Dividend | 54.7% |
Rel. Strength Industry | -4.14 |
Analysts | 4/5 |
Fair Price Momentum | 59.25 USD |
Fair Price DCF | 141.63 USD |
BUD Dividends
Dividend Yield 12m | 1.44% |
Yield on Cost 5y | 2.50% |
Annual Growth 5y | 9.19% |
Payout Consistency | 89.8% |
BUD Growth Ratios
Growth Correlation 3m | 57.8% |
Growth Correlation 12m | -36.8% |
Growth Correlation 5y | 15.5% |
CAGR 5y | 12.04% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | 0.38 |
Alpha | -1.74 |
Beta | 0.19 |
Volatility | 23.69% |
Current Volume | 2707.5k |
Average Volume 20d | 2475k |
As of March 16, 2025, the stock is trading at USD 62.34 with a total of 2,707,499 shares traded.
Over the past week, the price has changed by -1.14%, over one month by +17.36%, over three months by +18.68% and over the past year by +3.70%.
Neither. Based on ValueRay Fundamental Analyses, Anheuser Busch Inbev is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.41 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BUD as of March 2025 is 59.25. This means that BUD is currently overvalued and has a potential downside of -4.96%.
Anheuser Busch Inbev has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy BUD.
- Strong Buy: 4
- Buy: 3
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, BUD Anheuser Busch Inbev will be worth about 64 in March 2026. The stock is currently trading at 62.34. This means that the stock has a potential upside of +2.65%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 71.9 | 15.3% |
Analysts Target Price | 71.2 | 14.1% |
ValueRay Target Price | 64 | 2.6% |